Loading...
XSHG
603716
Market cap606mUSD
Jul 09, Last price  
23.28CNY
1D
9.86%
1Q
142.75%
Jan 2017
-35.35%
IPO
91.13%
Name

Thalys Medical Technology Group Corp

Chart & Performance

D1W1MN
XSHG:603716 chart
No data to show
P/E
—
P/S
2.17
EPS
—
Div Yield, %
—
Shrs. gr., 5y
0.13%
Rev. gr., 5y
8.77%
Revenues
2.01b
-13.10%
193,737,748283,166,616392,180,017445,045,201529,659,702627,328,056920,516,5441,317,446,0521,830,771,6162,125,471,6032,599,547,3482,308,631,6552,006,134,334
Net income
-159m
37,782,40038,330,98049,064,42456,518,10561,459,32768,917,86493,847,38594,159,095110,420,39482,034,68600-158,571,532
CFO
126m
+347.65%
-24,215,7002,699,20032,535,24030,065,36946,106,51100093,923,3649,944,111028,121,714125,886,030
Dividend
Jun 18, 20200.08 CNY/sh

Profile

Thalys Medical Technology Group Inc. engages in the medical intensive business and operation services in China. The company was formerly known as Thalys Medical Technology Inc. and changed its name to Thalys Medical Technology Group Inc. in September 2020. Thalys Medical Technology Group Inc. was founded in 2004 and is headquartered in Wuhan, China.
URL
https://www.thalys.net.cn/
IPO date
Oct 31, 2016
Employees
Domiciled in
CN
Incorporated in
CN

Valuation

Title
CNY in thousands, except ratios and share amounts
FYFYFYFYFYFYFYFYFY
2023‑122022‑122021‑122020‑122019‑122018‑122017‑122016‑122015‑12
Income
Revenues
2,006,134
-13.10%
2,308,632
-11.19%
Cost of revenue
1,868,759
2,089,212
Unusual Expense (Income)
NOPBT
137,376
219,419
NOPBT Margin
6.85%
9.50%
Operating Taxes
(35,728)
Tax Rate
NOPAT
173,104
219,419
Net income
(158,572)
 
Dividends
(38,796)
Dividend yield
1.81%
Proceeds from repurchase of equity
BB yield
Debt
Debt current
443,695
876,682
Long-term debt
629,621
590,854
Deferred revenue
65
145
Other long-term liabilities
21,527
48,820
Net debt
517,292
690,210
Cash flow
Cash from operating activities
125,886
28,122
CAPEX
(40,825)
Cash from investing activities
15,194
159,710
Cash from financing activities
(214,307)
FCF
607,400
509,676
Balance
Cash
278,586
394,544
Long term investments
277,438
382,783
Excess cash
455,717
661,895
Stockholders' equity
560,131
851,376
Invested Capital
1,921,017
2,283,920
ROIC
8.23%
8.78%
ROCE
5.75%
7.43%
EV
Common stock shares outstanding
193,380
190,834
Price
11.09
0.45%
11.04
-23.28%
Market cap
2,144,583
1.79%
2,106,812
-23.27%
EV
2,765,655
2,891,030
EBITDA
212,086
303,773
EV/EBITDA
13.04
9.52
Interest
76,188
98,760
Interest/NOPBT
55.46%
45.01%